Overview
Neelima Vidula is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Vidula is highly rated in 6 conditions, according to our data. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Paget Disease of the Breast, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Vidula is currently accepting new patients.
Her clinical research consists of co-authoring 40 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
3 Clinical Trials
Dana-Farber Cancer Institute, Inc.
David Reardon is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Philippe Armand is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Armand is highly rated in 29 conditions, according to our data. His top areas of expertise are Classical Hodgkin Lymphoma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Bone Marrow Transplant. Dr. Armand is currently accepting new patients.
Dana-Farber Cancer Institute, Inc.
Daniel Deangelo is a Hematologist Oncology specialist and a Hematologist in Boston, Massachusetts. Dr. Deangelo is highly rated in 35 conditions, according to our data. His top areas of expertise are Systemic Mastocytosis, Acute Myeloid Leukemia (AML), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Deangelo is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerDr. Vidula isElite. Learn about Breast Cancer.
- Distinguished
- AngiosarcomaDr. Vidula isDistinguished. Learn about Angiosarcoma.
- Inflammatory Breast CancerDr. Vidula isDistinguished. Learn about Inflammatory Breast Cancer.
- Paget Disease of the BreastDr. Vidula isDistinguished. Learn about Paget Disease of the Breast.
- Triple-Negative Breast CancerDr. Vidula isDistinguished. Learn about Triple-Negative Breast Cancer.
- Advanced
- Intraductal PapillomaDr. Vidula isAdvanced. Learn about Intraductal Papilloma.
- Experienced
- Bone Marrow AspirationDr. Vidula isExperienced. Learn about Bone Marrow Aspiration.
- Bone Marrow TransplantDr. Vidula isExperienced. Learn about Bone Marrow Transplant.
- HypophosphatemiaDr. Vidula isExperienced. Learn about Hypophosphatemia.
- Metastatic Brain TumorDr. Vidula isExperienced. Learn about Metastatic Brain Tumor.
- Trophoblastic Tumor Placental SiteDr. Vidula isExperienced. Learn about Trophoblastic Tumor Placental Site.